We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
In addition to being mission-driven, we contribute 5% of profits to charities that deliver health care to those in need.
In addition to being mission-driven, we contribute 5% of profits to charities that deliver health care to those in need.
In addition to being mission-driven, we contribute 5% of profits to charities that deliver health care to those in need.
We're working to improve health for all, including enhancing quality, reducing costs, and expanding access to care.
We're working to improve health for all, including enhancing quality, reducing costs, and expanding access to care.
We're working to improve health for all, including enhancing quality, reducing costs, and expanding access to care.
The Wynne Health Group is the only mission-driven, public interest government relations firm focused on health and well-being.
OUR SERVICES
If you believe that every American deserves to be healthy and well, contact the Wynne Health Group to learn how our expertise can help you achieve your goals.
Policy Hub, managed by Wynne Health Group, is the only comprehensive database of Federal health policy developments, cataloged by over 200 healthcare topics and programs. Regulations, reimbursement, grants, ACA implementation, hearing summaries, CRS Reports, pending legislation – you get it all here, with comprehensive, expert analysis.
Ways and Means Committee Examines H.R. 3, the Lower Drug Costs Now Act, and Education and Labor Committee Favorably Reports AINS to H.R. 3
The House Ways and Means Committee convened a hearing to discuss H.R. 3, the Lower Drug Costs Now Act (summary). The Ways and Means Committee is the third House Committee to examine the bill. Witnesses testified about the difficulties both privately insured beneficiaries and Medicare beneficiaries face in affording their medications and how H.R. 3 savings could be reinvested into… (Slifer, 10/17/19) #Insurance Reform, #Medicare Part D, #Prescription Drugs
Subcommittee Examines E-Cigarettes and Youth Tobacco Epidemic
The House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies convened a hearing to examine the Centers for Disease Control and Prevention’s (CDC) ongoing investigation of lung injury associated with e-cigarette use, discuss the youth tobacco epidemic, and identify public policy remedies. Overall, members from both parties agreed that efforts should be made to prevent children… (Llamas, 10/16/19) #Food and Drug Administration, #Pediatrics, #Public Health